Sara Semnani
About Sara
Sara Semnani practices corporate and securities law, counseling companies on formation and financing activities, securities law compliance, corporate governance matters and other strategic transactions, with a particular emphasis on representing clients in the life sciences industry. She counsels private companies at all stages, guiding them through their exit, and also focuses on representing issuers in their initial public offerings.
Experience
-
Electra Therapeutics Announces $183 Million Series C
-
Dualitas Therapeutics Launches With $65 Million Series A
-
Renasant Bio Launches With $54.5 Million Seed Financing
-
SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion
-
SiteOne Therapeutics Announces $100 Million Series C
Admissions and credentials
- California
Related services
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.